ArticleJACC. Case reports2025
Protruding Aortic Arch Thrombus in Cancer-Associated Stroke: Caution Regarding Endovascular Access.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn cancer-associated stroke, thrombi can be present beyond the cerebral vasculature. We report a case in which a protruding thrombus in the aortic arch was identified during the thrombectomy time window. CASE SUMMARY: A 65-year-old woman with stage IIIC2 endometrial cancer presented with aphasia and right hemiparesis. Magnetic resonance imaging showed acute cerebral infarction in the left temporal lobe with M2 occlusion. Contrast-enhanced imaging revealed multiple thrombi, including a protruding thrombus in the aortic arch as well as others in the celiac artery, pulmonary artery, and femoral veins. Although the patient was eligible for endovascular therapy, the procedure was deferred owing to high risk of further embolization. DISCUSSION: Endovascular therapy is a potential option in cancer-associated stroke but requires caution when aortic arch thrombi are present owing to increased embolic risk. TAKE-HOME MESSAGE: Comprehensive vascular imaging is essential in cancer-associated stroke to guide treatment and avoid procedural complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.